Yosei Kawamata

Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer.

T. Miyoshi, M. Ichiki, Y. Hiraki, 2016, Biological & pharmaceutical bulletin.

A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting

T. Miyoshi, T. Goto, M. Koyabu, 2017, Supportive Care in Cancer.

Association between pretreatment neutrophil‐to‐lymphocyte ratio and immune‐related adverse events due to immune checkpoint inhibitors in patients with non‐small cell lung cancer

G. Toyokawa, K. Yamazaki, S. Takeo, 2021, Thoracic cancer.

Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine‐coated polyacrylonitrile membrane

H. Tsukada, Y. Hiraki, Minako Tsuruta, 2020, Journal of clinical pharmacy and therapeutics.

Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study

T. Miyoshi, T. Goto, M. Koyabu, 2018, Cancer management and research.

Preparation and Evaluation of a Modified Mohs Paste Mixed with Zinc Oxide 10% Topical Oil-Based Ointment.

T. Miyoshi, K. Irie, Y. Hiraki, 2018, Journal of palliative medicine.

Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study

A. Ikari, S. Endo, Y. Hiraki, 2023, Cancer Immunology, Immunotherapy.

Predictors for the Clinical Efficacy of Tramadol for Cancer Pain

T. Miyoshi, Yosei Kawamata, Yasuhiro Yamaguchi, 2023, The American journal of hospice & palliative care.

Pharmacokinetics of linezolid during continuous hemodiafiltration: A case report.

T. Miyoshi, Y. Tsuji, Y. Hiraki, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.